Boston Trust Walden’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9M Sell
24,507
-11,234
-31% -$4.24M 0.09% 199
2026
Q1
$10.6M Sell
35,741
-416,012
-92% -$116M 0.09% 207
2025
Q4
$87.4M Sell
451,753
-159,529
-26% -$27.4M 0.66% 40
2025
Q3
$84.1M Buy
611,282
+183,883
+43% +$20.1M 0.62% 43
2025
Q2
$38.4M Buy
427,399
+22,635
+6% +$1.81M 0.27% 141
2025
Q1
$33.4M Sell
404,764
-3,413
-0.8% -$382K 0.24% 154
2024
Q4
$51.4M Buy
408,177
+13,020
+3% +$1.54M 0.36% 109
2024
Q3
$52.9M Buy
395,157
+3,837
+1% +$517K 0.37% 109
2024
Q2
$58M Sell
391,320
-27,992
-7% -$3.56M 0.43% 86
2024
Q1
$47.3M Buy
419,312
+358,317
+587% +$37.3M 0.34% 120
2023
Q4
$6.62M Buy
+60,995
New +$5.79M 0.05% 213

Other funds holding TER

Boston Trust Walden's TER Position: Q2 2026 in Review

Boston Trust Walden reduced its Teradyne (TER) stake by 31% in Q2 2026, selling an estimated $4.24M and leaving 24,507 shares worth $11.9M. The position accounts for 0.09% of the portfolio, ranked #199.

Boston Trust Walden first reported a position in TER in Q4 2023 and has held it in 11 quarters since. The position peaked at $87.4M in Q4 2025. 1,421 funds tracked by Wall St. Rank hold TER as of Q2 2026.

  • Boston Trust Walden held 24,507 shares of Teradyne worth $11.9M as of Q2 2026.
  • Boston Trust Walden sold 11,234 Teradyne shares in Q2 2026, an estimated $4.24M.
  • Teradyne made up 0.09% of Boston Trust Walden's portfolio in Q2 2026, its #199 holding.
  • Boston Trust Walden first reported a position in Teradyne in Q4 2023 and has held it in 11 quarters since.
  • Boston Trust Walden's Teradyne position peaked at $87.4M in Q4 2025.
  • 1,421 funds tracked by Wall St. Rank held Teradyne as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.